BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37173350)

  • 21. MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma.
    Wang Y; Liu Z; Xu H; Yang D; Jiang J; Asayo H; Yang Z
    BMC Med Imaging; 2023 May; 23(1):67. PubMed ID: 37254089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma.
    Che F; Xu Q; Li Q; Huang ZX; Yang CW; Wang LY; Wei Y; Shi YJ; Song B
    World J Gastroenterol; 2022 Apr; 28(14):1479-1493. PubMed ID: 35582676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma.
    Zhao YM; Xie SS; Wang J; Zhang YM; Li WC; Ye ZX; Shen W
    BMC Med Imaging; 2023 Sep; 23(1):138. PubMed ID: 37737166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic radiomics based on contrast-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma.
    Zhang R; Wang Y; Li Z; Shi Y; Yu D; Huang Q; Chen F; Xiao W; Hong Y; Feng Z
    BMC Med Imaging; 2024 Apr; 24(1):80. PubMed ID: 38584254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images.
    Wu J; Liu A; Cui J; Chen A; Song Q; Xie L
    BMC Med Imaging; 2019 Mar; 19(1):23. PubMed ID: 30866850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
    Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
    BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.
    Kuang Y; Li R; Jia P; Ye W; Zhou R; Zhu R; Wang J; Lin S; Pang P; Ji W
    Abdom Radiol (NY); 2021 Aug; 46(8):3772-3789. PubMed ID: 33713159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.
    Li SQ; Su LL; Xu TF; Ren LY; Chen DB; Qin WY; Yan XZ; Fan JX; Chen HS; Liao WJ
    World J Gastroenterol; 2023 Jul; 29(26):4186-4199. PubMed ID: 37475840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-based radiomics analysis to predict preoperative lymph node metastasis in papillary thyroid carcinoma.
    Hu W; Wang H; Wei R; Wang L; Dai Z; Duan S; Ge Y; Wu PY; Song B
    Gland Surg; 2020 Oct; 9(5):1214-1226. PubMed ID: 33224796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
    Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
    Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
    Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
    J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
    Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
    BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
    Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
    Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
    Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
    Yuan G; Song Y; Li Q; Hu X; Zang M; Dai W; Cheng X; Huang W; Yu W; Chen M; Guo Y; Zhang Q; Chen J
    Front Immunol; 2020; 11():613946. PubMed ID: 33488622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of MRI and CT for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma Based on a Non-Radiomics and Radiomics Method: Which Imaging Modality Is Better?
    Meng XP; Wang YC; Zhou JY; Yu Q; Lu CQ; Xia C; Tang TY; Xu J; Sun K; Xiao W; Ju S
    J Magn Reson Imaging; 2021 Aug; 54(2):526-536. PubMed ID: 33622022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.